Ameritas Investment Partners’s Sanara MedTech SMTI Stock Holding History

Ameritas Investment Partners’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.38K	Hold	313	–	–	﹤0.01%	2981
2025 Q4	$7.31K	Hold	313	–	–	﹤0.01%	2973
2025 Q3	$9.93K	Hold	313	–	–	﹤0.01%	2952
2025 Q2	$8.89K	Hold	313	–	–	﹤0.01%	3013
2025 Q1	$9.66K	Hold	313	–	–	﹤0.01%	2834
2024 Q4	$10.4K	Hold	313	–	–	﹤0.01%	2895
2024 Q3	$9.46K	Hold	313	–	–	﹤0.01%	2939
2024 Q2	$8.83K	Hold	313	–	–	﹤0.01%	2962
2024 Q1	$11.6K	Hold	313	–	–	﹤0.01%	2780
2023 Q4	$12.9K	Hold	313	–	–	﹤0.01%	2760
2023 Q3	$9.74K	Hold	313	–	–	﹤0.01%	2845
2023 Q2	$12.6K	Buy	+313	New	+$12.8K	﹤0.01%	2817

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ameritas Investment Partners's SMTI Position: Q1 2026 in Review

Ameritas Investment Partners held its Sanara MedTech (SMTI) position steady in Q1 2026 at 313 shares worth $5.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2981.

Ameritas Investment Partners first reported a position in SMTI in Q2 2023 and has held it in 12 quarters since. The position peaked at $12.9K in Q4 2023. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

Ameritas Investment Partners held 313 shares of Sanara MedTech worth $5.38K as of Q1 2026.
Ameritas Investment Partners left its Sanara MedTech share count unchanged in Q1 2026.
Sanara MedTech made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2981 holding.
Ameritas Investment Partners first reported a position in Sanara MedTech in Q2 2023 and has held it in 12 quarters since.
Ameritas Investment Partners's Sanara MedTech position peaked at $12.9K in Q4 2023.
65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.